Skip to main content
. 2020 Oct 13;15:2477–2486. doi: 10.2147/COPD.S265676

Table 1.

Baseline Characteristics of COPD Patients with Different BMIs (n=1644)

Characteristics Underweight (n=198) Normal Weight (n=757) Overweight (n=460) Obese (n=229) P value
Sex, male, n (%) 174 (87.9) 653 (86.3) 378 (82.2) 179 (78.2) 0.13
Age, yr 67.0±9.2 66.4±8.8 64.9±8.7 62.6±10.2 0.01
Neck Circumference, cm 35.1±2.7 37.4±2.6 39.5±3.0 42.3±4.3 <0.01
Degree of education, n (%) 0.03
 Under college 182 (92.0) 662 (87.5) 385 (83.7) 198 (86.5)
 Above college 16 (8.0) 95 (12.5) 75 (16.3) 31 (13.5)
Economic status, n (%) 0.51
 Higher income 0 (0.0) 12 (1.6) 8 (1.7) 2 (0.9)
 Middle income 19 (9.6) 74 (9.8) 48 (10.4) 18 (7.9)
 Lower income 179 (90.4) 671 (88.6) 404 (87.9) 209 (91.2)
Smoking status, n (%) <0.01
 Never 35 (17.7) 134 (17.7) 105 (22.8) 51 (22.3)
 Former 50 (25.3) 188 (24.8) 130 (28.3) 75 (32.7)
 Current 113 (57.0) 435 (57.5) 225 (48.9) 103 (45.0)
Alcohol consumption, n (%) 0.05
 Never 129 (65.2) 461 (60.9) 262 (57.0) 136 (59.4)
 Former 20 (10.1) 48 (6.3) 49 (10.6) 21 (9.2)
 Current 49 (24.7) 248 (32.8) 149 (32.4) 72 (31.4)
FVC, L 2.35±0.81 2.60±0.88 2.88±0.97 2.80±1.02 <0.01
FEV1, L 1.05±0.57 1.29±0.62 1.56±0.72 1.67±0.74 <0.01
FEV1% Predicted 41.65±18.71 50.75±22.10 59.22±23.23 62.05±22.20 <0.01
FEV1/FVC% Predicted 44.95±12.67 49.14±12.73 55.75±12.16 58.88±9.93 <0.01
Severity of COPD, n (%) <0.01
 GOLD 1 12 (6.1) 96 (12.7) 105 (22.8) 53 (23.1)
 GOLD 2 38 (19.2) 241 (31.8) 172 (37.5) 103 (45.0)
 GOLD 3 95 (48.0) 286 (37.8) 140 (30.4) 60 (26.2)
 GOLD 4 53 (26.7) 134 (17.7) 43 (9.3) 13 (5.7)
mMRC dyspnea scale 2.02±0.96 1.79±0.96 1.58±0.97 1.55±1.00 <0.01
Hypertension, n (%) 43 (21.7) 257 (33.9) 218 (47.4) 147 (64.2) <0.01
Diabetes mellitus, n (%) 7 (3.5) 60 (7.9) 69 (15.0) 51 (22.3) <0.01
Cardiovascular disease, n (%) 34 (17.2) 163 (21.5) 131 (28.5) 1 (39.7) <0.01
Cerebrovascular disease, n (%) 10 (5.1) 73 (9.6) 50 (10.9) 24 (10.5) 0.12
Osteoporosis, n (%) 3 (1.5) 24 (3.2) 14 (3.0) 4 (1.7) 0.45
COPD history, month, median (Q1,Q3) 60 (24, 120) 54 (14, 120) 36 (2, 84) 12 (0, 60) <0.01
`Events in previous year
 Acute exacerbation, n (%) 142 (71.7) 441 (58.3) 250 (54.3) 101 (44.1) <0.01
 NIV, n (%) 11 (5.6) 51 (6.7) 24 (5.2) 23 (10.0) 0.10
Blood cell analysis
 WBC, ×109/L 7.35±3.20 7.52±2.95 7.48±2.48 7.39±2.38 0.86
 RBC, ×1012/L 4.30±0.56 4.50±0.61 4.56±0.54 4.73±0.59 <0.01
 HB, g 129.2±16.16 136.7±17.5 140.2±16.17 143.0±17.4 <0.01
PLT, ×109/L 218.02±83.16 221.50±77.22 211.85±69.49 216.54±53.92 0.07

Notes: Continuous variables which are obviously skewed were presented as median (Q1, Q3), other continuous variables were described as means ±SD. Categorical variables were expressed as percentages. P value for the difference between the groups.

Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expiratory volume in the first second; GOLD 1, FEV1 ≥80% predicted; GOLD 2, FEV1=50–79% predicted; GOLD 3, FEV1=30–49% predicted; GOLD 4, FEV1 <30% predicted; mMRC, modified Medical Research Council; NIV, non-invasive ventilation; WBC, white blood cells; RBC, red blood cells; HB, hemoglobin; PLT, platelets.